Autoimmune Diseases

Advances in Neuroimmunology: From Bench to Bedside


Publishing date
14 Feb 2014
Status
Published
Submission deadline
27 Sep 2013

Lead Editor

1Department of Translational Medicine, University of Eastern Piedmont Amedeo Avogadro, Novara, Italy

2Department of Health Sciences, University of Eastern Piedmont Amedeo Avogadro, Novara, Italy

3Department of Neurorehabilitation and INSPE, San Raffaele Scientific Institute, Milan, Italy

4Department of Neurology, University of Connecticut Health Center, Farmington, CT, USA


Advances in Neuroimmunology: From Bench to Bedside

Description

The last decade has witnessed significant advances in the field of neuroimmunology. There has been an increased recognition of the role of the immune system in the etiology of neurological disorders and numerous novel therapies that have specific targeted interventions. In addition to significant advances in well-established disorders such as multiple sclerosis and inflammatory polyneuropathies (AIDP and CIDP), there has been significant knowledge acquisition regarding inflammatory responses in neurodegenerative diseases and the role of pathogenic antibodies responsible for neurological syndromes (i.e., antiaquaporin 4 in neuromyelitis optica (NMO) and anti-NMDA in autoimmune encephalitis). We are especially interested in contributions which propose novel techniques and methodological approaches capable of determining significant contributions to the field. In this regard, contributions on the expanding field of epigenetics will be privileged. Accordingly, we also encourage studies focusing on diseases of recent description, such as NMO or anti-NMDA encephalitis. We invite investigators to contribute original research and review articles that will expand the current knowledge base with respect to both basic mechanisms of neuroimmune interactions and treatments based on immunomodulation

Potential areas include, but are not limited to:

  • Basic principles of neuroimmune interactions
  • Role of the immunogenetic background in disease development and evolution
  • Role of cytokines, chemokines, or other inflammatory mediators in the regulation of basic and pathological mechanisms in the nervous system
  • Inflammatory and autoimmune diseases of the central nervous system, either idiopathic (e.g., multiple sclerosis, neuromyelitis optica, and idiopathic CNS vasculitis) or secondary to systemic diseases (e.g., systemic vasculitis and paraneoplastic syndromes)
  • Inflammatory and autoimmune diseases of the peripheral nervous system, either idiopathic (e.g., Guillain-Barrè syndrome, CIDP, and idiopathic PNS vasculitis) or secondary to systemic diseases (systemic vasculitis and paraneoplastic diseases)
  • Role of inflammation and autoimmunity in neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s, and Huntington’s diseases and amyotrophic lateral sclerosis)

Before submission authors should carefully read over the journal’s Author Guidelines, which are located at http://www.hindawi.com/journals/ad/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/submit/journals/ad/anm/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2014
  • - Article ID 812847
  • - Editorial

Advances in Neuroimmunology: From Bench to Bedside

Cristoforo Comi | Umberto Dianzani | ... | Daniel L. Menkes
  • Special Issue
  • - Volume 2014
  • - Article ID 201657
  • - Review Article

Treatment of Chronic Inflammatory Demyelinating Polyneuropathy: From Molecular Bases to Practical Considerations

Paolo Ripellino | Thomas Fleetwood | ... | Cristoforo Comi
  • Special Issue
  • - Volume 2014
  • - Article ID 793024
  • - Review Article

An Update in Guillain-Barré Syndrome

J. B. Winer
  • Special Issue
  • - Volume 2014
  • - Article ID 739705
  • - Review Article

Current Understanding on the Role of Standard and Immunoproteasomes in Inflammatory/Immunological Pathways of Multiple Sclerosis

Elena Bellavista | Aurelia Santoro | ... | Michele Mishto
  • Special Issue
  • - Volume 2013
  • - Article ID 741490
  • - Review Article

Immunotherapy of Neuromyelitis Optica

Benjamin Bienia | Roumen Balabanov
  • Special Issue
  • - Volume 2013
  • - Article ID 716813
  • - Review Article

An Update in the Use of Antibodies to Treat Glioblastoma Multiforme

Norma Y. Hernández-Pedro | Edgar Rangel-López | ... | Julio Sotelo
  • Special Issue
  • - Volume 2013
  • - Article ID 673947
  • - Review Article

Pediatric Multiple Sclerosis: Current Concepts and Consensus Definitions

Joaquin A. Pena | Timothy E. Lotze
Autoimmune Diseases
 Journal metrics
Acceptance rate-
Submission to final decision-
Acceptance to publication-
CiteScore2.190
Impact Factor-
 Submit

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.